Riskpilot← Back to searchSign inGet full accessUmbilical Talks AB
ABActiveOrg 5569960684Grev Turegatan 14Architectural activities · NACE 7111Est. 20140 employees
Revenue 2025
SEK 147K
-23% vs 2024
EBITDA margin
10.3%
-76% vs 2024
Equity ratio
28.7%
Financial strength
Net profit 2025
SEK -2K
-103% vs 2024
| Revenue | SEK 147K | -23% |
| EBITDA | SEK 15K | -76% |
| Net profit | SEK -2K | -103% |
| Total assets | SEK 90K | +3% |
| Equity | SEK 26K | -6% |
| Employees | 0 | — |
Legal name
Umbilical Talks AB
Org number
5569960684
Legal form
Aktiebolag
NACE code
7111 · Architectural activities
Founded
15 december 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsulttjänster och föredrag inom arkitektur och industridesign med inriktning på rymdindustri och extrema miljöer och därmed förenlig verksamhet.
Address
Grev Turegatan 14
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 166 | 418 | 242 | 191 | 147 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 90 | 145 | −76 | 63 | 15 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 90 | 145 | −76 | 63 | 15 |
| Net financials | — | −0 | −0 | −2 | −12 |
| Profit before tax | 90 | 145 | −76 | 61 | 3 |
| Tax | −22 | −40 | — | −9 | −4 |
| Net profit | 68 | 105 | −76 | 52 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 213 | 263 | 85 | 87 | 90 |
| Equity | 119 | 155 | −25 | 27 | 26 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 94 | 108 | 110 | 60 | 64 |
| Total debt | 94 | 108 | 110 | 60 | 64 |
EBITDA margin
10.3%
This company
15.8%
Market median
-35% vs market
20212025
Equity ratio
28.7%
This company
38.2%
Market median
-25% vs market
20212025
Return on equity
-5.8%
This company
18.4%
Market median
-132% vs market
20212025
Net profit margin
-1.0%
This company
8.1%
Market median
-112% vs market
20212025
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20212025
Debt / equity
2.48×
This company
0.62×
Market median
-300% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Umbilical Talks AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Cecilia Josefine Hertz | Chief Executive Officer | 0 companies |
| Rut Annette Hertz | Deputy Board Member | 0 companies |